最近の論文

*基本的にはFirst authorかCorresponding authorが当研究室員である英語論文を掲載しています。

論文業績のFull listはこちら(PubMedへのリンクです。著者名で検索しているため誤りを含む可能性があります。)

2017

Khvostunov IK, Saenko VA, Krylov V, Rodichev A, Yamashita S
Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer
Radiat Environ Biophys, 56: 213-226, 2017 [PubMed]
Suzuki K
Analyzing ATM Function by Electroporation of Endonucleases and Immunofluorescence Microscopy
Methods Mol Biol, 1599: 85-96, 2017 [PubMed]
Iyama K, Matsuse M, Mitsutake N, Rogounovitch T, Saenko VA, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H, Fukushima T, Suzuki S, Yamashita S
Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima
Thyroid, 27: 811-818, 2017 [PubMed]
Yamashita S, Saenko V
What Is the "Screening Effect" Six Years After the Fukushima Nuclear Power Plant Accident?
Thyroid, 27: 595-596, 2017 [PubMed]
Matsuse M, Yabuta T, Saenko V, Hirokawa M, Nishihara E, Suzuki K, Yamashita S, Miyauchi A, Mitsutake N
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
Sci Rep, 7: 41752, 2017 [PubMed]
Yamashita S
Shigenobu Nagataki (January 18, 1932-November 12, 2016)
Thyroid, 27: 135-136, 2017 [PubMed]
Nikitski A, Rogounovitch T, Bychkov A, Takahashi M, Yoshiura KI, Mitsutake N, Kawaguchi T, Matsuse M, Drozd VM, Demidchik YE, Nishihara E, Hirokawa M, Miyauchi A, Rubanovich AV, Matsuda F, Yamashita S, Saenko VA
Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma
Thyroid, 27: 224-235, 2017 [PubMed]
Saenko V, Thomas G, Yamashita S
Meeting report: the 5th International expert symposium in Fukushima on radiation and health
Environ Health, 16: 3 [PubMed]

2016

Yamashita S, Takamura N, Ohtsuru A, Suzuki S
Radiation Exposure and Thyroid Cancer Risk After the Fukushima Nuclear Power Plant Accident in Comparison with the Chernobyl Accident.
Radiat Prot Dosimetry, 171: 41-46, 2016 [PubMed]
Suzuki S, Suzuki S, Fukushima T, Midorikawa S, Shimura H, Matsuzuka T, Ishikawa T, Takahashi H, Ohtsuru A, Sakai A, Hosoya M, Yasumura S, Nollet KE, Ohira T, Ohto H, Abe M, Kamiya K, Yamashita S
Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years After the Fukushima Daiichi Nuclear Power Plant Accident
Thyroid, 26: 843-851, 2016 [PubMed]
Yamashita S; Radiation Medical Science Center for the Fukushima Health Management Survey
Comprehensive Health Risk Management after the Fukushima Nuclear Power Plant Accident
Clin Oncol, 28: 255-262, 2016 [PubMed]
Nikitski A, Saenko V, Shimamura M, Nakashima M, Matsuse M, Suzuki K, Rogounovitch T, Bogdanova T, Shibusawa N, Yamada M, Nagayama Y, Yamashita S, Mitsutake N
Targeted Foxe1 overexpression in mouse thyroid causes the development of multinodular goiter but does not promote carcinogenesis
Endocrinology, 157: 2182-2195, 2016 [PubMed]

2015

Mitsutake N, Fukushima T, Matsuse M, Rogounovitch T, Saenko V, Uchino S, Ito M, Suzuki K, Suzuki S, Yamashita S
BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl
Sci Rep, 5: 16976, 2015 [PubMed]
Drozd VM, Saenko VA, Brenner AV, Drozdovitch V, Pashkevich VI, Kudelsky AV, Demidchik YE, Branovan I, Shiglik N, Rogounovitch TI, Yamashita S, Biko J, Reiners C
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?
PLoS One, 10: e0137226, 2015 [PubMed]
Suzuki K, Mitsutake N, Saenko V, Yamashita S
Radiation signatures in childhood thyroid cancers after the Chernobyl accident: Possible roles of radiation in carcinogenesis
Cancer Sci, 106: 127-133, 2015, Review [PubMed]
Rogounovitch T, Bychkov A, Takahashi M, Mitsutake N, Nakashima M, Nikitski A, Hayashi T, Hirokawa M, Ishigaki K, Shigematsu K, Bogdanova TI, Matsuse M, Nishihara E, Minami S, Yamanouchi K, Ito M, Kawaguchi T, Kondo H, Takamura N, Ito Y, Miyauchi A, Matsuda F, Yamashita S, Saenko V
The common genetic variant rs944289 at chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in Japanese population
Thyroid, 25: 333-340, 2105 [PubMed]
Leonova TA, Drozd VM, Saenko VA, Mine M, Biko J, Rogounovitch TI, Takamura N, Reiners C, Yamashita S
Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation
Endocr J, 62: 173-182, 2015 [PubMed]
Inamasu T, Schonfeld SJ, Abe M, Bidstrup PE, Deltour I, Ishida T, Ishikawa T, Kesminiene A, Ohira T, Ohto H, Suzuki S, Thierry-Chef I, Yabe H, Yasumura S, Schüz J, Yamashita S
Meeting report: suggestions for studies on future health risks following the Fukushima Accident
Environ Health, 14: 26, 2015 [PubMed]
Yamashita S, Takamura N
Post-crisis efforts towards recovery and resilience after the Fukushima Daiichi Nuclear Power Plant accident
Jpn J Clin Oncol, 45: 700-707, 2015, Review [PubMed]
Suzuki K, Yamashita S
Perspective: Health-Risk Implications of the Fukushima Nuclear Power Plant Accident
Fukushima Nuclear Accident: global implications, long-term health effects, and ecological consequences, 1-25, Nova Science Publishers, New York, 2015
Niwa O, Barcellos-Hoff MH, Globus RK, Harrison JD, Hendry JH, Jacob P, Martin MT, Seed TM, Shay JW, Story MD, Suzuki K, Yamashita S, Authors on behalf of ICRP
ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection
Ann ICRP, 44: 7-357, 2015
[PubMed]

2014

Tronko MD, Saenko VA, Shpak VM, Bogdanova TI, Suzuki S, Yamashita S
Age Distribution of Childhood Thyroid Cancer Patients in Ukraine After Chernobyl and in Fukushima After the TEPCO-Fukushima Daiichi NPP Accident
Thyroid, 24: 1547-1548, 2014 [PubMed]
Suzuki K, Yamashita S
Radiation-Induced Bystander Response: Mechanism and Clinical Implications
Adv Wound Care, 3: 16-24, 2014, Review [PubMed]
Yamashita S
Fukushima nuclear power plant accident and comprehensive health risk management-global radiocontamination and information disaster.
Trop Med Health, 42: 93-107, 2014 [PubMed]
Mori K, Suzuki K, Hozumi A, Goto H, Tomita M, Koseki H, Yamashita S, Osaki M
Potentiation of osteoclastogenesis by adipogenic conversion of bone marrow-derived mesenchymal stem cells
Biomed Res, 35: 153-159, 2014 [PubMed]
Shimamura M, Nagayama Y, Matsuse M, Yamashita S, Mitsutake N
Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines
Endocr J, 61: 481-490, 2014 [PubMed]
Orim F, Bychkov A, Shimamura M, Nakashima M, Ito M, Matsuse M, Kurashige T, Suzuki K, Saenko V, Nagayama Y, Yamashita S, Mitsutake N
Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAFV600E-induced thyroid tumors in a mouse model
Thyroid, 24: 502-510, 2014 [PubMed]
Yamashita S
Tenth Warren K. Sinclair keynote address-the Fukushima nuclear power plant accident and comprehensive health risk management
Health Phys, 106: 166-180 [PubMed]